Huili Pharmaceutical Overview

  • Year Founded
  • 2020

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Series A

  • Latest Deal Amount
  • $14M

  • Investors
  • 4

Huili Pharmaceutical General Information

Description

Developer of long-acting sustained-release microsphere new drug technologies designed to transform drug delivery processes. The company's technologies focus on addressing needs in the field of chronic diseases and filling the domestic clinical gaps, enabling medical research institutes to leverage long-acting sustained-release microsphere preparation technologies.

Contact Information

Website
www.huillypharma.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 5th Floor, Building C17, No. 218 Xinghu Street, Suzhou Industrial Park
  • Suzhou Area, China Free Trade Pilot Zone
  • Suzhou, Jiangsu 215125
  • China
+86 0512
Primary Industry
Drug Delivery
Corporate Office
  • 5th Floor, Building C17, No. 218 Xinghu Street, Suzhou Industrial Park
  • Suzhou Area, China Free Trade Pilot Zone
  • Suzhou, Jiangsu 215125
  • China
+86 0512

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Huili Pharmaceutical Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Early Stage VC (Series A) 13-Dec-2023 $14M Completed Generating Revenue
To view Huili Pharmaceutical’s complete valuation and funding history, request access »

Huili Pharmaceutical Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
Jiashan Xingxiang Investment Venture Capital Minority
Suzhou Industrial Park Venture Capital Fund Government Minority
Tai Partners Venture Capital Minority
YuanBio Venture Capital Venture Capital Minority
To view Huili Pharmaceutical’s complete investors history, request access »

Ready to get started?

Request a free trial

Huili Pharmaceutical FAQs

  • When was Huili Pharmaceutical founded?

    Huili Pharmaceutical was founded in 2020.

  • Where is Huili Pharmaceutical headquartered?

    Huili Pharmaceutical is headquartered in Suzhou, China.

  • What industry is Huili Pharmaceutical in?

    Huili Pharmaceutical’s primary industry is Drug Delivery.

  • Is Huili Pharmaceutical a private or public company?

    Huili Pharmaceutical is a Private company.

  • What is Huili Pharmaceutical’s current revenue?

    The current revenue for Huili Pharmaceutical is .

  • How much funding has Huili Pharmaceutical raised over time?

    Huili Pharmaceutical has raised $14M.

  • Who are Huili Pharmaceutical’s investors?

    Jiashan Xingxiang Investment, Suzhou Industrial Park Venture Capital Fund, Tai Partners, and YuanBio Venture Capital have invested in Huili Pharmaceutical.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process